Depression
Latest News
Postpartum depression risk higher with family psych history
The risk for PPD was almost twice as high for mothers who have any psychiatric disorder in their family history compared with mothers who don’t....
Conference Coverage
What ketamine and psilocybin can and cannot do in depression
While ketamine is only suitable for acute intervention, owing to the short duration of effect, the effects of psilocybin can last for weeks or...
Opinion
Postpartum psychosis: Does longitudinal course inform treatment?
The good news is we’ve seen an evolution of both interest and expertise in acute management of postpartum psychosis and a richer appreciation of...
Supplements
Federal Health Care Data Trends 2022
News
A ‘promising target’ to improve outcomes in late-life depression
Older adults with depression and comorbid apathy have poorer outcomes, including lower remission rates and poorer response to first-line...
Commentary
Reassessing benzodiazepines: What role should this medication class play in psychiatry?
Benzodiazepines are appropriate and helpful in situations that cause transient anxiety and with patients who have done poorly with other options...
Opinion
Burnout and stress of today: How do we cope?
“I am reminded every day of the commitment and excellence of my colleagues in the health care field, and I do not want to lose them.”
News
B6 a new approach for depression, anxiety?
Some previous research has suggested that vitamins B6 and B12 have a role in improving mood-related outcomes.
News
Pharmacogenomic testing may curb drug interactions in severe depression
Some physicians have expressed scepticism about pharmacogenomic testing, but the study provides additional evidence of its usefulness.
News
Hospital programs tackle mental health effects of long COVID
Patients never hospitalized for COVID-19 still may have persistent symptoms like fatigue, cognitive problems, and mood disorders.